韩国末期癌症患者慢性疾病的药物处方:现实世界研究
Mina Kim1, Yonghwan Kim2, Jae-Min Park3,4
1Department of Data Science, Hanmi Pharm. Co., Ltd., Seoul, Korea.
在韩国,许多绝症癌症患者继续接受临近死亡的慢性病药物治疗. 这种做法与指导方针相矛盾,可能会对他们的生活质量产生负面影响.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 慢性病的管理是复杂的终末期癌症患者.
- 指导方针建议随着预期寿命的下降,对药物进行审查.
研究的目的:
- 调查韩国绝症癌症患者慢性疾病的处方模式.
- 随着预期寿命的减少,评估药物使用情况.
主要方法:
- 分析韩国国家健康保险服务 (NHIS) 数据.
- 包括2021年去世的89,606名癌症患者.
- 在死亡前的不同时间间隔内检查过血脂不良,高血压,糖尿病和骨质疏松症的处方.
主要成果:
- 有相当数量的临死患者接受了慢性病药物治疗.
- 2.6%的患者在死亡前一周被处方为失脂症药物.
- 观察到临床实践与推指南之间的差异.
结论:
- 对癌症末期患者的处方实践进行重新评估是必要的.
- 优化药物使用可以减少多药和药物不良反应.
- 改善药物管理可以提高这些患者的生活质量.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
